Integra Lifesciences Holdings Corp
NASDAQ:IART 4:00:00 PM EDT
| Market Cap (Intraday) | 1.36B |
| Current PE | 57.38 |
| Forward PE | 7.14 |
| 2yr Forward PE | 7 |
| 10-Day MA | $17.43 |
| 50-Day MA | $19.71 |
| 200-Day MA | $30.80 |
Integra Lifesciences Holdings Corp Stock, NASDAQ:IART
1100 Campus Road, Princeton, New Jersey 08540
United States of America
Phone: +1.609.275.0500
Number of Employees: 5329
Description
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.